# Postoperative Management of the Cardiac Surgery Patient

## Introduction

The postoperative care of the cardiac surgery patient requires a systematic, protocol-driven approach to manage the complex physiological derangements that follow cardiopulmonary bypass (CPB), cardioplegic arrest, and surgical trauma. Early recognition and treatment of hemodynamic instability, bleeding, arrhythmias, and organ dysfunction are essential for optimizing outcomes. This lecture addresses the critical first 24-72 hours following cardiac surgery.

## Immediate ICU Arrival and Assessment

### Handoff Protocol

Structured handoff from the operating room team to the ICU team is a patient safety imperative. Key elements include the procedure performed, CPB and cross-clamp times, cardioplegia strategy, intraoperative complications, hemodynamic status, vasoactive medications, estimated blood loss, and coagulation status. Chest tube placement, temporary pacing wires, and invasive monitoring lines must be confirmed. Standardized checklists such as the I-PASS framework reduce communication errors by 30%.

### Initial Assessment

A systematic head-to-toe examination is performed upon arrival. Endotracheal tube position is confirmed, and a chest radiograph and arterial blood gas are obtained within 15 minutes. Baseline hemodynamics are established from arterial blood pressure, central venous pressure, and cardiac output/index (if a PA catheter is present). The initial lab panel includes CBC, metabolic panel, coagulation studies, lactate, and ionized calcium.

## Hemodynamic Management

### Low Cardiac Output Syndrome

Low cardiac output syndrome occurs in 3-14% of cardiac surgery patients and is defined as a cardiac index below 2.0 L/min/m2 with signs of end-organ hypoperfusion. Causes include myocardial stunning, incomplete revascularization, valvular dysfunction, tamponade, and vasodilatory shock. | Agent | Mechanism | Dose Range | Best Indication | Cautions |
| --- | --- | --- | --- | --- | --- |
| Dobutamine | Beta-1 agonist | 2.5-10 mcg/kg/min | First-line inotrope for low CO | Tachycardia, arrhythmias |  |
| Milrinone | PDE-3 inhibitor (inodilator) | 0.25-0.75 mcg/kg/min | Low CO with pulmonary hypertension | Hypotension; renally cleared |  |
| Epinephrine | Alpha + beta agonist | 0.01-0.1 mcg/kg/min | Refractory low CO | Arrhythmogenicity, lactic acidosis |  |
| Norepinephrine | Alpha-1 > beta-1 agonist | 0.05-0.5 mcg/kg/min | Vasoplegia (first-line vasopressor) | Peripheral ischemia at high doses |  |
| Vasopressin | V1 receptor agonist | 0.01-0.04 U/min | Vasoplegia (second-line) | Mesenteric ischemia |  |

First-line inotropes are dobutamine (a beta-1 agonist) and milrinone (a PDE-3 inhibitor with inodilator properties). Milrinone is preferred when pulmonary hypertension is present due to its pulmonary vasodilatory effect. Epinephrine is reserved for refractory low output but should be used with caution due to arrhythmogenicity and lactate production. Mechanical circulatory support (IABP, Impella, ECMO) is deployed for cardiogenic shock unresponsive to pharmacotherapy.

### Vasoplegia

Vasoplegic syndrome presents as mean arterial pressure below 60 mmHg with low systemic vascular resistance despite adequate cardiac output. Risk factors include preoperative ACEi/ARB use, prolonged CPB time, and preoperative heart failure. The management ladder proceeds from norepinephrine (first-line) to vasopressin (0.01-0.04 U/min), and then methylene blue (1.5-2 mg/kg) for refractory cases. Hydroxocobalamin has emerged as an alternative to methylene blue.

![Algorithm for postoperative hemodynamic management in cardiac surgery](images/postop-hemodynamic-algorithm.png)

### Hypertension

Hypertension is common after CABG and risks suture line bleeding, aortic dissection propagation, and graft disruption. The target systolic BP is typically below 140 mmHg (or per surgeon preference). Clevidipine or nicardipine infusions provide rapid, titratable control. Adequate analgesia and sedation should be ensured before escalating antihypertensives.

## Bleeding and Coagulation Management

### Postoperative Bleeding

Expected chest tube output is less than 200 mL/hr in the first hour, tapering to less than 100 mL/hr by hours 2-3. Surgical re-exploration is indicated for output exceeding 400 mL in the first hour, more than 300 mL/hr for 2-3 hours, or sudden massive hemorrhage. Re-exploration rates are approximately 2-4%, and delay beyond 12 hours increases mortality. Common surgical sources include internal mammary artery branches, sternal wires, cannulation sites, and aortotomy suture lines.

### Coagulopathy After CPB

CPB causes dilutional coagulopathy, platelet dysfunction, fibrinolysis, and consumption of clotting factors. Point-of-care testing (TEG/ROTEM) guides targeted transfusion and reduces empiric blood product use. Protamine reversal of heparin (1 mg per 100 units) is confirmed with ACT. Tranexamic acid is the standard antifibrinolytic, reducing transfusion by 30-40%. Platelet transfusion is given for counts below 100,000/microL with active bleeding or demonstrated platelet dysfunction. FFP and cryoprecipitate are guided by coagulation studies and viscoelastic testing, targeting fibrinogen above 200 mg/dL.

## Respiratory Management

### Ventilator Strategy

Lung-protective ventilation uses tidal volumes of 6-8 mL/kg ideal body weight and PEEP of 5-8 cmH2O. Fast-track extubation within 4-6 hours is safe and preferred in uncomplicated patients. Criteria for extubation include hemodynamic stability, adequate gas exchange, minimal bleeding, normothermia, and appropriate neurological status. Early extubation reduces VAP risk, ICU length of stay, and costs.

### Pulmonary Complications

Atelectasis is nearly universal and is addressed with incentive spirometry, chest physiotherapy, and early mobilization. Pleural effusions occur in 40-50% of patients and are more common on the left side after LIMA harvest. Phrenic nerve injury (1-5%) may cause diaphragm paralysis and prolonged ventilation. Pneumothorax should be excluded on the initial chest radiograph.

![Chest radiograph showing expected findings after sternotomy with mediastinal drains](images/postop-cxr-cardiac.png)

## Neurological Monitoring

Stroke occurs in 1-3% of CABG procedures and 3-8% of valve procedures. Delayed awakening requires evaluation for metabolic derangements, residual sedation, seizure, or stroke. CT head is indicated if a focal deficit is present or the patient fails to awaken within 6-8 hours of sedation cessation. Postoperative delirium affects 25-50% of cardiac surgery patients, and CAM-ICU is used for screening. Delirium prevention strategies include minimizing benzodiazepines, maintaining sleep-wake cycles, early mobilization, and reorientation protocols.

## Renal and Metabolic Management

Acute kidney injury occurs in 20-30% of patients, with 2-5% requiring renal replacement therapy. Adequate perfusion pressure (MAP above 65-75 mmHg), avoidance of nephrotoxins, and maintenance of euvolemia are essential. Glycemic control targets glucose of 140-180 mg/dL with insulin infusion while avoiding hypoglycemia. Electrolyte management targets potassium at 4.0-5.0 mEq/L and magnesium above 2.0 mg/dL to reduce arrhythmia risk. Ionized calcium correction is essential for myocardial contractility and coagulation.

## Postoperative Arrhythmias

Atrial fibrillation is the most common arrhythmia, occurring in 20-40% after CABG and 40-60% after valve surgery, with peak incidence on postoperative days 2-3. Prophylaxis involves continuing beta-blockers, correcting electrolytes, and administering amiodarone in high-risk patients. Treatment uses rate control with beta-blockers or amiodarone, and cardioversion for hemodynamic instability. Anticoagulation is initiated for AF persisting beyond 48 hours per CHA2DS2-VASc scoring.

![Timeline of common complications after cardiac surgery by postoperative day](images/postop-complication-timeline.png)

## Key Clinical Pearls

Structured ICU handoff with a standardized checklist significantly reduces adverse events in the immediate postoperative period. Point-of-care coagulation testing (TEG/ROTEM) enables goal-directed transfusion and reduces unnecessary blood product exposure. Fast-track extubation within 4-6 hours is safe for most patients and should be the default pathway. Postoperative atrial fibrillation peaks on POD 2-3, and prophylactic beta-blocker continuation and electrolyte optimization are the most effective preventive strategies. Lactate clearance within 6-12 hours is a reliable indicator of adequate resuscitation and end-organ perfusion.

## References

1. Engelman DT, Ben Ali W, Williams JB, et al. Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. *JAMA Surg*. 2019;154(8):755-766.
2. Stephens RS, Whitman GJ. Postoperative Critical Care of the Adult Cardiac Surgical Patient. *Crit Care Med*. 2015;43(7):1477-1497.
3. Myles PS, Smith JA, Forbes A, et al. Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. *N Engl J Med*. 2017;376(2):136-148.
4. Kulik A, Ruel M, Jneid H, et al. Secondary Prevention After Coronary Artery Bypass Graft Surgery. *Circulation*. 2015;131(10):927-964.